Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients
Recruiting
- Conditions
- Carbon Dioxide
- Interventions
- Device: VA-ECMO
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT04445909
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Effect of Dupilumab on Aspirin Intolerance
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT04442256
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Nerve Transfers in Post-stroke Spasticity
Not Applicable
- Conditions
- Nerve TransfersSpasticity as Sequela of Stroke
- Interventions
- Procedure: Cognitive nerve transfers to spastic upper extremity muscles in stroke patients
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT04437056
- Locations
- 🇦🇹
General Hospital of Vienna, Vienna, Austria
Intracranial Pressure (ICP) Monitoring Following Traumatic Brain Injury (TBI)
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Procedure: Invasive ICP monitoring
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 214
- Registration Number
- NCT04428970
- Locations
- 🇦🇹
Medical Universtiy of Vienna, Vienna, Austria
Vienna Versus SARS-CoV-2 Virus Study
- Conditions
- SARS-CoV-2COVID-19
- Interventions
- Diagnostic Test: Laboratory Analyses
- First Posted Date
- 2020-05-29
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 12000
- Registration Number
- NCT04407429
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Characterisation of the Nasal Microbiome in Patients With N-ERD
Not Applicable
Completed
- Conditions
- Chronic RhinitisAspirin Exacerbated Respiratory Disease
- Interventions
- Other: Microbiome swabs
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 80
- Registration Number
- NCT04375293
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Posterior Capsule Opafication of Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs.Clareon IOL
Not Applicable
- Conditions
- Age Related Cataracts
- Interventions
- Device: Hoya VivinexDevice: Alcon Clareon
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 100
- Registration Number
- NCT04369482
- Locations
- 🇦🇹
Medical University of Vienna Allgemeines Krankenhaus, Vienna, Austria
Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections
Completed
- Conditions
- Sars-CoV2Viral InfectionCovid19Critical IllnessDisseminated Intravascular CoagulationCoagulation Disorder, Blood
- Interventions
- Diagnostic Test: Thrombin Generation Assay (TGA)Diagnostic Test: Thrombomodulin Modified Thrombin Generation Assay (TGA-TM)
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 58
- Registration Number
- NCT04356144
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Phase 2
- Conditions
- COVID-19
- Interventions
- Drug: Chloroquine or HydroxychloroquineDrug: Lopinavir/RitonavirOther: Best standard of careDrug: Asunercept 100mgDrug: Asunercept 400mgDrug: non-RAS blocking antihypertensivesDrug: Asunercept 25mgDrug: RemdesivirDrug: ThromboprophylaxisDrug: RivaroxabanDrug: CandesartanDrug: Pentaglobin
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 500
- Registration Number
- NCT04351724
- Locations
- 🇦🇹
Medical University of Innsbruck, Innsbruck, Tirol, Austria
🇦🇹Wilhelminenspital, Vienna, Austria
🇦🇹SMZ Ost Donauspital, Vienna, Austria
FGF-23 and PTH in Hemodialysis Patients
Completed
- Conditions
- Chronic Kidney Disease Requiring Chronic Dialysis
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT04350944
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath